New patent expiration for Osi Pharms drug TARCEVA
Annual Drug Patent Expirations for TARCEVA Tarceva is a drug marketed by Osi Pharms and is included in one NDA. […]
New patent expiration for Osi Pharms drug TARCEVA Read Post »
Annual Drug Patent Expirations for TARCEVA Tarceva is a drug marketed by Osi Pharms and is included in one NDA. […]
New patent expiration for Osi Pharms drug TARCEVA Read Post »
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA.
New patent expiration for Cumberland Pharms drug VIBATIV Read Post »
AMONDYS 45 (casimersen) Sarepta theraps inc Patent: 10,533,174 Expiration: May 4, 2021 See More … For more information on how
Drug Patent Expirations for the Week of May 2, 2021 Read Post »
Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug STRIBILD Read Post »
Annual Drug Patent Expirations for TRUVADA Truvada is a drug marketed by Gilead and is included in one NDA. It
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug COMPLERA Read Post »
Annual Drug Patent Expirations for DESCOVY Descovy is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug DESCOVY Read Post »
Annual Drug Patent Expirations for GENVOYA Genvoya is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug GENVOYA Read Post »
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug ODEFSEY Read Post »
Get fresh news and insights, drug patent expirations & more…